Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702992 | American Journal of Ophthalmology | 2017 | 7 Pages |
Abstract
Rare intraocular manifestations of ECD confirmed on histopathology can be imaged with multimodal imaging. We report 3 cases, including 1 case diagnosed through histology from chorioretinal biopsy and another case associated with a novel ARAF mutation responsive to targeted therapy with sorafenib. The identification of novel somatic mutation associated with ECD enabled treatment with a new-targeted systemic agent. Multimodal imaging in these cases can also be used to monitor response to therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Anna C.S. Tan, Suzanne Yzer, Neal Atebara, Brian P. Marr, Robert M. Verdijk, Virgil A.S.H. Dalm, K. Bailey Freund, Lawrence Yannuzzi, Tom Missotten,